First Turn Management, LLC

Investment Portfolio & 13F Holdings Analysis

About

CIK: 0001993440

Type: FundHoldings: 35Value: $496.1MLatest: 2025Q1

First Turn Management, LLC is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 35 holdings worth $0.5 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

AI_NATIVE detailed information: This accession holds the following tickers:[
  "MRUS",
  "NUVL",
  "AXSM",
  "ASND",
  "INSM",
  "RVMD",
  "ORIC",
  "ARGX",
  "RDNT",
  "EXAS",
  "TGTX",
  "ADMA",
  "BSX",
  "SWTX",
  "MIRM",
  "JANX",
  "APGE",
  "ISRG",
  "GH",
  "PODD",
  "HQY",
  "SPRY",
  "PRAX",
  "MLTX",
  "SLNO",
  "GKOS",
  "NTRA",
  "ELVN",
  "HROW",
  "VRNA",
  "XENE",
  "VERA",
  "PCVX",
  "BPMC",
  "BBIO"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 35
Total Value: 496050761
Accession Number: 0001085146-25-003195
Form Type: 13F-HR
CIK: first-turn-management
Manager Name: First-Turn-Management

Data Enrichment

100% identified

35 identified0 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

35 positions • $496.1M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 1 of 2

Sort by:

INSMED Inc

INSM|457669307

Shares:401.6K

Value:$30.6M

% of Portfolio:6.2% ($30.6M/$496.1M)

Verona Pharma plc

VRNA|925050106

Shares:435.4K

Value:$27.6M

% of Portfolio:5.6% ($27.6M/$496.1M)

ARGENX SE

ARGX|04016X101

Shares:41.9K

Value:$24.8M

% of Portfolio:5.0% ($24.8M/$496.1M)

Nuvalent, Inc.

NUVL|670703107

Shares:331.9K

Value:$23.5M

% of Portfolio:4.7% ($23.5M/$496.1M)

Xenon Pharmaceuticals Inc.

XENE|98420N105

Shares:683.5K

Value:$22.9M

% of Portfolio:4.6% ($22.9M/$496.1M)

BridgeBio Pharma, Inc.

BBIO|10806X102

Shares:656.7K

Value:$22.7M

% of Portfolio:4.6% ($22.7M/$496.1M)

Mirum Pharmaceuticals, Inc.

MIRM|604749101

Shares:503.0K

Value:$22.7M

% of Portfolio:4.6% ($22.7M/$496.1M)

Natera, Inc.

NTRA|632307104

Shares:139.9K

Value:$19.8M

% of Portfolio:4.0% ($19.8M/$496.1M)

Merus N.V.

MRUS|N5749R100

Shares:464.0K

Value:$19.5M

% of Portfolio:3.9% ($19.5M/$496.1M)

BOSTON SCIENTIFIC CORP

BSX|101137107

Shares:178.2K

Value:$18.0M

% of Portfolio:3.6% ($18.0M/$496.1M)

Ascendis Pharma A/S

ASND|04351P101

Shares:113.3K

Value:$17.7M

% of Portfolio:3.6% ($17.7M/$496.1M)

TG THERAPEUTICS, INC.

TGTX|88322Q108

Shares:400.6K

Value:$15.8M

% of Portfolio:3.2% ($15.8M/$496.1M)

Vera Therapeutics, Inc.

VERA|92337R101

Shares:623.6K

Value:$15.0M

% of Portfolio:3.0% ($15.0M/$496.1M)

Axsome Therapeutics, Inc.

AXSM|05464T104

Shares:118.2K

Value:$13.8M

% of Portfolio:2.8% ($13.8M/$496.1M)

Guardant Health, Inc.

GH|40131M109

Shares:315.7K

Value:$13.5M

% of Portfolio:2.7% ($13.5M/$496.1M)

SpringWorks Therapeutics, Inc.

SWTX|85205L107

Shares:304.1K

Value:$13.4M

% of Portfolio:2.7% ($13.4M/$496.1M)

GLAUKOS Corp

GKOS|377322102

Shares:136.2K

Value:$13.4M

% of Portfolio:2.7% ($13.4M/$496.1M)

EXACT SCIENCES CORP

EXAS|30063P105

Shares:300.9K

Value:$13.0M

% of Portfolio:2.6% ($13.0M/$496.1M)

INSULET CORP

PODD|45784P101

Shares:49.4K

Value:$13.0M

% of Portfolio:2.6% ($13.0M/$496.1M)

Revolution Medicines, Inc.

RVMD|76155X100

Shares:340.1K

Value:$12.0M

% of Portfolio:2.4% ($12.0M/$496.1M)

Instrument	Shares		Other Manager	Value	% of Portfolio
INSMED Inc(INSMcusip457669307)	401.6K	QoQ -10.14% (-45.4K) YoY NEW(+401.6K)	All Managers (Combined)	$30.6M	6.2% ($30.6M/$496.1M)	QoQ -0.71% (-$219.2K) YoY NEW(+$30.6M)
Verona Pharma plc(VRNAcusip925050106)	435.4K	QoQ -32.17% (-206.5K) YoY -55.25% (-537.7K)	All Managers (Combined)	$27.6M	5.6% ($27.6M/$496.1M)	QoQ -7.27% (-$2.2M) YoY +76.54% (-$12.0M)
ARGENX SE(ARGXcusip04016X101)	41.9K	QoQ -2.70% (-1.2K) YoY -47.59% (-38.1K)	All Managers (Combined)	$24.8M	5.0% ($24.8M/$496.1M)	QoQ -6.36% (-$1.7M) YoY -21.22% (-$6.7M)
Nuvalent, Inc.(NUVLcusip670703107)	331.9K	QoQ +7.23% (-22.4K) YoY +24.83% (+66.0K)	All Managers (Combined)	$23.5M	4.7% ($23.5M/$496.1M)	QoQ -2.84% (-$689.0K) YoY +17.90% (+$3.6M)
Xenon Pharmaceuticals Inc.(XENEcusip98420N105)	683.5K	QoQ -0.22% (-1.5K) YoY +0.45% (-3.1K)	All Managers (Combined)	$22.9M	4.6% ($22.9M/$496.1M)	QoQ -14.60% (-$3.9M) YoY -21.71% (-$6.4M)
BridgeBio Pharma, Inc.(BBIOcusip10806X102)	656.7K	QoQ +45.19% (+204.4K) YoY NEW(+656.7K)	All Managers (Combined)	$22.7M	4.6% ($22.7M/$496.1M)	QoQ +82.92% (+$10.3M) YoY NEW(+$22.7M)
Mirum Pharmaceuticals, Inc.(MIRMcusip604749101)	503.0K	QoQ -0.76% (-3.9K) YoY -47.52% (-455.6K)	All Managers (Combined)	$22.7M	4.6% ($22.7M/$496.1M)	QoQ +8.11% (-$1.7M) YoY -5.89% (-$1.4M)
Natera, Inc.(NTRAcusip632307104)	139.9K	QoQ +41.12% (+40.8K) YoY NEW(+139.9K)	All Managers (Combined)	$19.8M	4.0% ($19.8M/$496.1M)	QoQ +26.07% (+$4.1M) YoY NEW(+$19.8M)
Merus N.V.(MRUScusipN5749R100)	464.0K	QoQ +62.70% (+178.8K) YoY NEW(+464.0K)	All Managers (Combined)	$19.5M	3.9% ($19.5M/$496.1M)	QoQ +62.85% (+$7.5M) YoY NEW(+$19.5M)
BOSTON SCIENTIFIC CORP(BSXcusip101137107)	178.2K	QoQ NEW(+178.2K) YoY NEW(+178.2K)	All Managers (Combined)	$18.0M	3.6% ($18.0M/$496.1M)	QoQ NEW(+$18.0M) YoY NEW(+$18.0M)
Ascendis Pharma A/S(ASNDcusip04351P101)	113.3K	QoQ +29.01% (+25.5K) YoY -25.27% (-38.3K)	All Managers (Combined)	$17.7M	3.6% ($17.7M/$496.1M)	QoQ +46.05% (+$5.6M) YoY -22.95% (-$5.3M)
TG THERAPEUTICS, INC.(TGTXcusip88322Q108)	400.6K	QoQ NEW(+400.6K) YoY NEW(+400.6K)	All Managers (Combined)	$15.8M	3.2% ($15.8M/$496.1M)	QoQ NEW(+$15.8M) YoY NEW(+$15.8M)
Vera Therapeutics, Inc.(VERAcusip92337R101)	623.6K	QoQ +34.16% (-158.8K) YoY +427.32% (+505.4K)	All Managers (Combined)	$15.0M	3.0% ($15.0M/$496.1M)	QoQ -23.79% (-$4.7M) YoY +193.74% (+$9.9M)
Axsome Therapeutics, Inc.(AXSMcusip05464T104)	118.2K	QoQ -38.49% (-74.0K) YoY -65.46% (-224.0K)	All Managers (Combined)	$13.8M	2.8% ($13.8M/$496.1M)	QoQ -15.21% (-$2.5M) YoY -49.52% (-$13.5M)
Guardant Health, Inc.(GHcusip40131M109)	315.7K	QoQ NEW(+315.7K) YoY NEW(+315.7K)	All Managers (Combined)	$13.5M	2.7% ($13.5M/$496.1M)	QoQ NEW(+$13.5M) YoY NEW(+$13.5M)
SpringWorks Therapeutics, Inc.(SWTXcusip85205L107)	304.1K	QoQ NEW(+304.1K) YoY NEW(+304.1K)	All Managers (Combined)	$13.4M	2.7% ($13.4M/$496.1M)	QoQ NEW(+$13.4M) YoY NEW(+$13.4M)
GLAUKOS Corp(GKOScusip377322102)	136.2K	QoQ +41.77% (-40.1K) YoY NEW(+136.2K)	All Managers (Combined)	$13.4M	2.7% ($13.4M/$496.1M)	QoQ -6.93% (-$999.9K) YoY NEW(+$13.4M)
EXACT SCIENCES CORP(EXAScusip30063P105)	300.9K	QoQ -2.89% (-9.0K) YoY NEW(+300.9K)	All Managers (Combined)	$13.0M	2.6% ($13.0M/$496.1M)	QoQ -25.19% (-$4.4M) YoY NEW(+$13.0M)
INSULET CORP(PODDcusip45784P101)	49.4K	QoQ NEW(+49.4K) YoY NEW(+49.4K)	All Managers (Combined)	$13.0M	2.6% ($13.0M/$496.1M)	QoQ NEW(+$13.0M) YoY NEW(+$13.0M)
Revolution Medicines, Inc.(RVMDcusip76155X100)	340.1K	QoQ -15.79% (-63.8K) YoY NEW(+340.1K)	All Managers (Combined)	$12.0M	2.4% ($12.0M/$496.1M)	QoQ -31.92% (-$5.6M) YoY NEW(+$12.0M)